Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

LEVAQUIN 5MG/ML DIN 02236839

Status: Cancelled Post Market
Holder: JANSSEN INC
Molecule: LEVOFLOXACIN

Health Canada record

Active ingredient(s)LEVOFLOXACIN 5 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01MA12 LEVOFLOXACIN
Original market date28-Nov-1997
Current status date19-Mar-2014
SourceHealth Canada DPD

Establishment licence of the holder

Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LEVOFLOXACIN

DINProductCompanyFormStrengthStatus
02537079LEVOFLOXACIN IN 5% DEXTROSE INJECTIONHIKMA CANADA LIMITEDSolutionLEVOFLOXACIN 5 MGMarketed
02460122LEVOFLOXACIN IN 5% DEXTROSE INJECTIONSTERIMAX INCSolutionLEVOFLOXACIN 5 MGApproved
02314932LEVOFLOXACIN IN 5% DEXTROSE INJECTIONPFIZER CANADA ULCSolutionLEVOFLOXACIN 5 MGMarketed
02361027AVA-LEVOFLOXACINAVANSTRA INCTabletLEVOFLOXACIN 250 MGCancelled Post Market
02361035AVA-LEVOFLOXACINAVANSTRA INCTabletLEVOFLOXACIN 500 MGCancelled Post Market
02236841LEVAQUINJANSSEN INCTabletLEVOFLOXACIN 250 MGCancelled Post Market
02236840LEVAQUIN 25MG/MLJANSSEN INCSolutionLEVOFLOXACIN 25 MGCancelled Post Market
02236842LEVAQUIN 500MGJANSSEN INCTabletLEVOFLOXACIN 500 MGCancelled Post Market
02246804LEVAQUIN 750MGJANSSEN INCTabletLEVOFLOXACIN 750 MGCancelled Post Market
02358670NTP-LEVOFLOXACINTEVA CANADA LIMITEDTabletLEVOFLOXACIN 750 MGCancelled Pre Market
02358662NTP-LEVOFLOXACINTEVA CANADA LIMITEDTabletLEVOFLOXACIN 500 MGCancelled Pre Market
02358654NTP-LEVOFLOXACINTEVA CANADA LIMITEDTabletLEVOFLOXACIN 250 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
39091997-11-14New Drug Submission (NDS)

International API supply for LEVOFLOXACIN

23 active FDA Drug Master Files.

Request a quote for LEVAQUIN 5MG/ML

How to read a Canadian DIN record